This paper introduces some comments on the complete text of Good Pharm
acovigilance Publishing Practices, which forms appendix number 2 of th
e Good Pharmacovigilance Practices now published by the French Drug Ag
ency, as was Good Clinical Practices. Each good practice is printed in
italic and presented in a frame; the following comments are designed
to facilitate its application. The technical terms that are used in th
is text are presented according to the glossary in Good Pharmacovigila
nce Practices.